| 0.174 -0.088 (-33.59%) | 09-25 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.35 |
1-year : | 0.45 |
| Resists | First : | 0.3 |
Second : | 0.39 |
| Pivot price | 0.27 |
|||
| Supports | First : | 0.16 |
Second : | 0.13 |
| MAs | MA(5) : | 0.24 |
MA(20) : | 0.29 |
| MA(100) : | 0.45 |
MA(250) : | 1.08 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 15.3 |
D(3) : | 19.5 |
| RSI | RSI(14): 24.5 |
|||
| 52-week | High : | 2.89 | Low : | 0.16 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NXGL ] has closed below the lower bollinger band by 27.8%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 10.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.24 - 0.24 | 0.24 - 0.24 |
| Low: | 0.16 - 0.16 | 0.16 - 0.16 |
| Close: | 0.17 - 0.17 | 0.17 - 0.18 |
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
Thu, 24 Sep 2026
NexGel Shareholders Approve Stock Expansion and Split - The Globe and Mail
Thu, 24 Sep 2026
NexGel begins using strategic review presentation on proposed platform reorganization - TradingView
Thu, 24 Sep 2026
A strategic review is the focus of a new shareholder presentation from NexGel (NXGL). - stocktitan.net
Wed, 23 Sep 2026
NEXGEL Announces Dial-In Details for Investor Update Call - globenewswire.com
Wed, 16 Sep 2026
NEXGEL Announces Date for Investor Update Call - globenewswire.com
Thu, 20 Aug 2026
NXGL | NexGel, Inc Common Stock Financials - Revenue Breakdown - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 10 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 14 (%) |
| Held by Institutions | 13.6 (%) |
| Shares Short | 269 (K) |
| Shares Short P.Month | 172 (K) |
| EPS | -0.75 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.5 |
| Profit Margin | -51.3 % |
| Operating Margin | -68 % |
| Return on Assets (ttm) | -18.7 % |
| Return on Equity (ttm) | -115.1 % |
| Qtrly Rev. Growth | 27.7 % |
| Gross Profit (p.s.) | 0.43 |
| Sales Per Share | 1.23 |
| EBITDA (p.s.) | -0.44 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | -0.24 |
| PEG Ratio | 0 |
| Price to Book value | 0.34 |
| Price to Sales | 0.14 |
| Price to Cash Flow | -0.53 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|